ReviewSpringer seminars in immunopathology1994
Complement resistance in microbes.
Review in Springer seminars in immunopathology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 50 citations in OpenAlex.
- Article
- Increased severity of respiratory infections associated with elevated anti-LPS IgG2 which inhibits serum bactericidal killing.The Journal of experimental medicine · 2014Article
- Functional characterization of exopolyphosphatase/guanosine pentaphosphate phosphohydrolase (PPX/GPPA) of Campylobacter jejuni.Virulence · 2014Article
- Complement and autoimmunity.Immunologic research · 2013Review
- Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis.Infection and immunity · 2010Article
- Aptamer–biotin–streptavidin–C1q complexes can trigger the classical complement pathway to kill cancer cells.In vitro cellular & developmental biology. Animal · 2010Article
- Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.International journal of medical microbiology : IJMM · 2007Review
- Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy.Cancer immunology, immunotherapy : CII · 2005Article
- Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding.Infection and immunity · 2005Article
- BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition.Infection and immunity · 2001Article
- Characterization of human bactericidal antibodies to Bordetella pertussis.Infection and immunity · 1999Article
- Characterization of BrkA expression in Bordetella bronchiseptica.Infection and immunity · 1998Article
- Animal models for complement deficiencies.Journal of clinical immunology · 1995Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.